Zydus Hospira Oncology Private Limited — Gemcitabine Exporter Profile
Indian Pharmaceutical Exporter · #8 for Gemcitabine · $2.1M export value · DGFT Verified
Zydus Hospira Oncology Private Limited is the #8 Indian exporter of Gemcitabine with $2.1M in export value and 42 verified shipments. Zydus Hospira Oncology Private Limited holds a 4.5% market share in Gemcitabine exports across 9 countries. The company exports 5 pharmaceutical products worth $4.7M across 2 therapeutic categories.
Zydus Hospira Oncology Private Limited — Gemcitabine Export Profile: Buyers & Destinations
Where Does Zydus Hospira Oncology Private Limited Export Gemcitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES OF AMERICA | $509.3K | 11 | 35.2% |
| UNITED STATES | $390.7K | 8 | 27.0% |
| BELGIUM | $263.3K | 8 | 18.2% |
| AUSTRALIA | $200.0K | 4 | 13.8% |
| ALGERIA | $50.0K | 1 | 3.5% |
| HONG KONG | $20.1K | 2 | 1.4% |
| CANADA | $6.8K | 1 | 0.5% |
| SOUTH KOREA | $3.5K | 1 | 0.2% |
| CZECH REPUBLIC | $2.4K | 5 | 0.2% |
| SINGAPORE | $1.1K | 1 | 0.1% |
Zydus Hospira Oncology Private Limited exports Gemcitabine to 10 countries. The largest destination is UNITED STATES OF AMERICA accounting for 35.2% of Zydus Hospira Oncology Private Limited's Gemcitabine shipments, followed by UNITED STATES (27.0%) and BELGIUM (18.2%). These destinations reflect Zydus Hospira Oncology Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Gemcitabine from Zydus Hospira Oncology Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| XXIZEXXSERXXCE XXMPAXX BV | CZECH REPUBLIC | $779.5K | 24 |
| PFIZER SERVICE COMPANY BV | HONG KONG | $517.7K | 15 |
| HOSPIRA INC | UNITED STATES | $100.0K | 2 |
| XXDUSXXIFEXXIENXXS LXX (XXRMEXXY KXXWN XX CAXXLA | ALGERIA | $50.0K | 1 |
Zydus Hospira Oncology Private Limited supplies Gemcitabine to 4 buyers globally. The largest buyer is XXIZEXXSERXXCE XXMPAXX BV (CZECH REPUBLIC), followed by PFIZER SERVICE COMPANY BV (HONG KONG) and HOSPIRA INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Gemcitabine Export Value and How Much Does Zydus Hospira Oncology Private Limited Contribute?
India exported $36.6M worth of Gemcitabine through 2,938 shipments from 248 suppliers to 125 countries, serving 676 buyers globally. Zydus Hospira Oncology Private Limited contributes $2.1M to this total, accounting for 4.5% of India's Gemcitabine exports. Zydus Hospira Oncology Private Limited ships Gemcitabine to 10 countries through 4 buyers.
What Is the Average Shipment Value for Zydus Hospira Oncology Private Limited's Gemcitabine Exports?
Zydus Hospira Oncology Private Limited's average Gemcitabine shipment value is $50.0K per consignment, based on 42 shipments totaling $2.1M. The largest destination is UNITED STATES OF AMERICA (35.2% of Zydus Hospira Oncology Private Limited's Gemcitabine exports).
How Does Zydus Hospira Oncology Private Limited Compare to Other Indian Gemcitabine Exporters?
Zydus Hospira Oncology Private Limited ranks #8 among 248 Indian Gemcitabine exporters with a 4.5% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($6.9M), EUGIA PHARMA SPECIALITIES LIMITED ($5.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($5.8M). Zydus Hospira Oncology Private Limited processed 42 shipments to 9 destination countries.
What Gemcitabine Formulations Does Zydus Hospira Oncology Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GEMCITABINE INJECTION 2G US-F000206913 | $481.5K | 10 |
| GEMCITABINE INJ. 2G AU/NZ - F000046485 | $200.0K | 4 |
| GEMCITABINE INJ. 200MG US - F000206916 | $118.5K | 3 |
| GEMCITABINE INJ.2G-BR-H000205209 | $110.7K | 7 |
| GEMCITABINE INJECTION 1G US-F000206903 | $100.0K | 2 |
| ZYGEM 1G INJECTION (GEMCITABINE | $50.0K | 1 |
| GEMCITABINE INJ. 1G US N+ F000206904 | $50.0K | 1 |
| GEMCITABINE INJ.200MG-ES-F000057726 | $50.0K | 1 |
| GEMCITABINE FOR INJ. 2G US-F000206930 | $50.0K | 1 |
| GEMCITABINE FOR INJ. 1G US-F000206928 | $50.0K | 1 |
Zydus Hospira Oncology Private Limited exports 21 distinct Gemcitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GEMCITABINE INJECTION 2G US-F000206913 with 10 shipments worth $481.5K.
Regulatory Requirements: Exporting Gemcitabine to Key Markets
What Zydus Hospira Oncology Private Limited must comply with to export Gemcitabine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Zydus Hospira Oncology Private Limited Compare to Nearest Gemcitabine Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | ACCURE LABS PRIVATE LIMITED | $3.1M | 107 | 2 | $29.0K |
| 9 | VENUS REMEDIES LIMITED | $2.2M | 189 | 23 | $11.6K |
| 8 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED ★ | $2.1M | 42 | 9 | $50.0K |
| 7 | JODAS EXPOIM PRIVATE LIMITED | $1.8M | 35 | 2 | $50.0K |
| 4 | MYLAN LABORATORIES LIMITED | $1.6M | 32 | 1 | $50.0K |
Zydus Hospira Oncology Private Limited ranks #8 among 248 Indian Gemcitabine exporters. Average shipment value of $50.0K compared to the market average of $147.4K. The closest competitors by value are ACCURE LABS PRIVATE LIMITED and VENUS REMEDIES LIMITED.
Which Indian Ports Ship Gemcitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 538 | 18.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 393 | 13.4% |
| SAHAR AIR | 370 | 12.6% |
| DELHI AIR | 358 | 12.2% |
| Delhi Air | 131 | 4.5% |
| HYDERABAD ICD (INSNF6) | 88 | 3.0% |
| Bombay Air | 77 | 2.6% |
| NHAVA SHEVA SEA (INNSA1) | 66 | 2.2% |
What Other Oncology Products Does Zydus Hospira Oncology Private Limited Export?
Zydus Hospira Oncology Private Limited also exports these oncology products. Each links to the detailed product page.
About Zydus Hospira Oncology Private Limited
Zydus Hospira Oncology Private Limited exports 5 products worth $4.7M. Beyond Gemcitabine, top products include Oxaliplatin, Irinotecan, Docetaxel, Cytarabine. View the complete Zydus Hospira Oncology Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gemcitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gemcitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Hospira Oncology Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 42 individual customs records matching Zydus Hospira Oncology Private Limited exporting Gemcitabine, covering 21 formulations to 10 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 125+ countries, 676+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gemcitabine Export Data from Zydus Hospira Oncology Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Hospira Oncology Private Limited's Gemcitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Hospira Oncology Private Limited
Full Company Profile →
5 products · $4.7M total trade · 2 categories
Gemcitabine Stats
Company Overview
Top Products by Zydus Hospira Oncology Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Hospira Oncology Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gemcitabine. For current shipment-level data, contact TransData Nexus.